Skip to main content
Top
Published in: Odontology 1/2020

01-01-2020 | Antiepileptic Drugs | Original Article

The number and kind of antiepileptics affect propofol dose requirement for anesthesia: observational study

Author: Kentaro Ouchi

Published in: Odontology | Issue 1/2020

Login to get access

Abstract

The propofol dose requirement and the emergence time are affected by antiepileptic use. The effects on anesthesia of the number and kind of antiepileptic agents have not been reported. We investigated the relationship between the kind and number of antiepileptic agents and the propofol dose requirement for anesthesia and emergence time in intravenous general anesthesia for dental treatment for patients with neurological disorders. We studied 247 patients with neurological disorders who underwent dental treatment under intravenous general anesthesia. Patients were categorized according to the number of antiepileptics (none, single agent, two kinds, and three or more kinds of antiepileptics) and the kind of antiepileptic (carbamazepine, valproate, phenobarbital, phenytoin, zonisamide, clobazam, or topiramate) being received. The propofol dose requirement for anesthesia, emergence time, and predicted blood propofol concentration at emergence were evaluated. Patients on three or more kinds of antiepileptics had significantly lower propofol dose requirement (reduction in 25%, compare with no use) and predicted blood propofol concentration at emergence (reduction in 41%) and significantly longer emergence time (extension in 50%) (P < 0.05). Valproate and clobazam reduced the propofol dose (valproate 9% and clobazam 19%) and predicted blood propofol concentration at emergence (valproate 18% and clobazam 33%), while phenobarbital increased these parameters (30% and 125%) (P < 0.05). The number and kind of antiepileptics effects propofol dose requirement. In particular, valproate and clobazam reduce the propofol dose requirement, while phenobarbital increases this.
Clinical trial registration UMIN No. UMIN000014179.
Literature
1.
go back to reference Manley MC, Skelly AM, Hamilton AG. Dental treatment for people with challenging behaviour: general anaesthesia or sedation? Br Dent J. 2000;188(7):358–60.CrossRef Manley MC, Skelly AM, Hamilton AG. Dental treatment for people with challenging behaviour: general anaesthesia or sedation? Br Dent J. 2000;188(7):358–60.CrossRef
2.
go back to reference Miyawaki T, Kohjitani A, Maeda S, Egusa M, Mori T, Higuchi H, et al. Intravenous sedation for dental patients with intellectual disability. J Intellect Disabil Res JIDR. 2004;48(Pt 8):764–8.CrossRef Miyawaki T, Kohjitani A, Maeda S, Egusa M, Mori T, Higuchi H, et al. Intravenous sedation for dental patients with intellectual disability. J Intellect Disabil Res JIDR. 2004;48(Pt 8):764–8.CrossRef
3.
go back to reference Asahi Y, Kubota K, Omichi S. Dose requirements for propofol anaesthesia for dental treatment for autistic patients compared with intellectually impaired patients. Anaesth Intensive Care. 2009;37(1):70–3.CrossRef Asahi Y, Kubota K, Omichi S. Dose requirements for propofol anaesthesia for dental treatment for autistic patients compared with intellectually impaired patients. Anaesth Intensive Care. 2009;37(1):70–3.CrossRef
4.
go back to reference Ouchi K, Sugiyama K. Required propofol dose for anesthesia and time to emerge are affected by the use of antiepileptics: prospective cohort study. BMC Anesthesiol. 2015;15:34.CrossRef Ouchi K, Sugiyama K. Required propofol dose for anesthesia and time to emerge are affected by the use of antiepileptics: prospective cohort study. BMC Anesthesiol. 2015;15:34.CrossRef
5.
go back to reference Ouchi K, Fujiwara S, Sugiyama K. Acoustic method respiratory rate monitoring is useful in patients under intravenous anesthesia. J Clin Monit Comput. 2017;31(1):59–65.CrossRef Ouchi K, Fujiwara S, Sugiyama K. Acoustic method respiratory rate monitoring is useful in patients under intravenous anesthesia. J Clin Monit Comput. 2017;31(1):59–65.CrossRef
6.
go back to reference Soehle M, Wolf CF, Priston MJ, Neuloh G, Bien CG, Hoeft A, et al. Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: a prospective observational study. Eur J Anaesthesiol. 2015;32(8):527–34.CrossRef Soehle M, Wolf CF, Priston MJ, Neuloh G, Bien CG, Hoeft A, et al. Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: a prospective observational study. Eur J Anaesthesiol. 2015;32(8):527–34.CrossRef
7.
go back to reference Zhou SF, Zhou ZW, Yang LP, Cai JP. Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480–675.CrossRef Zhou SF, Zhou ZW, Yang LP, Cai JP. Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480–675.CrossRef
8.
go back to reference Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia. 2007;48(3):435–41.CrossRef Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia. 2007;48(3):435–41.CrossRef
9.
go back to reference Faucette SR, Wang H, Hamilton GA, Jolley SL, Gilbert D, Lindley C, et al. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos. 2004;32(3):348–58.CrossRef Faucette SR, Wang H, Hamilton GA, Jolley SL, Gilbert D, Lindley C, et al. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos. 2004;32(3):348–58.CrossRef
10.
go back to reference Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43(4):365–85.CrossRef Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43(4):365–85.CrossRef
11.
go back to reference Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30(8):1385–407.CrossRef Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30(8):1385–407.CrossRef
12.
go back to reference Andersson T, Hassan-Alin M, Hasselgren G, Rohss K. Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet. 2001;40(7):523–37.CrossRef Andersson T, Hassan-Alin M, Hasselgren G, Rohss K. Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet. 2001;40(7):523–37.CrossRef
13.
go back to reference Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46(2):145–55.CrossRef Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46(2):145–55.CrossRef
14.
go back to reference Inoue T, Matsumoto R, Ikeda A. Treatment of epilepsy in patients of adolescence and adulthood. Nihon Rinsho. 2014;72(5):853–8.PubMed Inoue T, Matsumoto R, Ikeda A. Treatment of epilepsy in patients of adolescence and adulthood. Nihon Rinsho. 2014;72(5):853–8.PubMed
15.
go back to reference Tsuji S. Clinical guidelines for epilepsy. Nihon Rinsho. 2014;72(5):803–8.PubMed Tsuji S. Clinical guidelines for epilepsy. Nihon Rinsho. 2014;72(5):803–8.PubMed
16.
go back to reference Hayashi T, Higuchi H, Tomoyasu Y, Ishii-Maruhama M, Maeda S, Miyawaki T. Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study. J Anesth. 2016;30(1):166–9.CrossRef Hayashi T, Higuchi H, Tomoyasu Y, Ishii-Maruhama M, Maeda S, Miyawaki T. Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study. J Anesth. 2016;30(1):166–9.CrossRef
Metadata
Title
The number and kind of antiepileptics affect propofol dose requirement for anesthesia: observational study
Author
Kentaro Ouchi
Publication date
01-01-2020
Publisher
Springer Japan
Published in
Odontology / Issue 1/2020
Print ISSN: 1618-1247
Electronic ISSN: 1618-1255
DOI
https://doi.org/10.1007/s10266-019-00457-z

Other articles of this Issue 1/2020

Odontology 1/2020 Go to the issue